Background Human adipose stromal cells-derived extracellular vesicles (haMSC-EVs) have
been shown to alleviate inflammation in acute lung injury (ALI) animal models. However …

Mesenchymal stromal cell‐derived extracellular vesicles (MSC‐EVs) turn out to be a
promising source of cell‐free therapy. Here, we investigated the biodistribution and effect of …

Background Mesenchymal stromal cell-derived extracellular vesicles (MSC-EVs) are a
promising cell-free therapy for acute lung injury (ALI). To date, no studies have investigated …

Background: Mesenchymal stem cells (MSCs)-derived extracellular vesicles (EVs) have
been proposed as an alternative to live-cell administration for Acute Respiratory Distress …

Abstract Background aims Extracellular vesicles (EVs) represent a new axis of intercellular
communication that can be harnessed for therapeutic purposes, as cell-free therapies. The …

Extracellular vesicles (EVs) derived from human adipose mesenchymal stem cells
(hADSCs) may exert a therapeutic benefit in alleviating sepsis-induced organ dysfunction by …

Mesenchymal stem cell derived extracellular vesicles (MSC-EVs) are bioactive particles that
evoke beneficial responses in recipient cells. We identified a role for MSC-EV in immune …

Acute respiratory distress syndrome (ARDS) is a devastating and life-threatening syndrome
that results in high morbidity and mortality. Current pharmacologic treatments and …

Background Exposure to PM2. 5 (fine particulate matter≤ 2.5 μm in aerodynamic diameter)
in air increases the risk of lung injury and pulmonary fibrosis (PF). Extracellular vesicles …

Mesenchymal stem cell-derived small extracellular vesicles (MSC-EVs) are promising
nanotherapeutic agent for pneumonia (bacterial origin, COVID-19), but the optimal …